The homeobox only protein homeobox (HOPX) and colorectal cancer

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 23231-23243

  Yamashita, Keishi ^a   Katoh, Hiroshi ^a   Watanabe, Masahiko ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; HOPX; Methylation; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CETUXIMAB; CYSTEINE RICH PROTEIN 61; EARLY GROWTH RESPONSE FACTOR 1; EPHRIN RECEPTOR A2; GEFITINIB; GLUCOSE TRANSPORTER 3; HISTONE DEACETYLASE 2; HOMEOBOX ONLY PROTEIN HOMEOBOX; HOMEODOMAIN PROTEIN; PANITUMUMAB; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR NKX2.2; TRICHOSTATIN A; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR AP 1;

CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; COLORECTAL CANCER; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE STRUCTURE; GOBLET CELL; HOPX GENE; HUMAN; LUNG CANCER; NONHUMAN; ONCOGENE C FOS; REVIEW; STEM CELL; TUMOR DIFFERENTIATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; RECEPTOR, EPHA2; TRANSCRIPTION FACTOR AP-1;

EID: 84888327294     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141223231     Document Type: Review

References (52)

1. Chen, F.; Kook, H.; Milewski, R.; Gitler, A. D.; Lu, M. M.; Li, J.; Nazarian, R.; Schnepp, R.; Jen, K.; Biben, C.; et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 2002, 110, 713-723.
2. Shin, C. H.; Liu, Z. P.; Passier, R.; Zhang, C. L.; Wang, D. Z.; Harris, T. M.; Yamagishi, H.; Richardson, J. A.; Childs, G.; Olson, E. N. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 2002, 110, 725-735.
3. Kook, H.; Lepore, J. J.; Gitler, A. D.; Lu, M. M.; Wing-Man Yung, W.; Mackay, J.; Zhou, R.; Ferrari, V.; Gruber, P.; Epstein, J. A. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Investig. 2003, 112, 863-871.
4. Trivedi, C. M.; Zhu, W.; Wang, Q.; Jia, C.; Kee, H. J.; Li, L.; Hannenhalli, S.; Epstein, J. A. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev. Cell 2010, 19, 450-459.
5. Kee, H. J.; Kim, J. R.; Nam, K. I.; Park, H. Y.; Shin, S.; Kim, J. C.; Shimono, Y.; Takahashi, M.; Jeong, M. H.; Kim, N.; et al. Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J. Biol. Chem. 2007, 282, 7700-7709.
6. Asanoma, K.; Kato, H.; Inoue, T.; Matsuda, T.; Wake, N. Analysis of a candidate gene associated with growth suppression of choriocarcinoma and differentiation of trophoblasts. J. Reprod. Med. 2004, 49, 617-626.
7. Asanoma, K.; Kato, H.; Yamaguchi, S.; Shin, C. H.; Liu, Z. P.; Kato, K.; Inoue, T.; Miyanari, Y.; Yoshikawa, K.; Sonoda, K.; et al. HOP/NECC1, a novel regulator of mouse trophoblast differentiation. J. Biol. Chem. 2007, 282, 24065-24074.
8. Yang, J. M.; Sim, S. M.; Kim, H. Y.; Park, G. T. Expression of the homeobox gene, HOPX, is modulated by cell differentiation in human keratinocytes and is involved in the expression of differentiation markers. Eur. J. Cell Biol. 2010, 89, 537-546.
9. Obarzanek-Fojt, M.; Favre, B.; Kypriotou, M.; Ryser, S.; Huber, M.; Hohl, D. Homeodomain-only protein HOP is a novel modulator of late differentiation in keratinocytes. Eur. J. Cell Biol. 2011, 90, 279-290.
10. Hawiger, D.; Wan, Y. Y.; Eynon, E. E.; Flavell, R. A. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 2010, 11, 962-968.
11. Albrecht, I.; Niesner, U.; Janke, M.; Menning, A.; Loddenkemper, C.; Kühl, A. A.; Lepenies, I.; Lexberg, M. H.; Westendorf, K.; Hradilkova, K.; et al. Persistence of effector memory Th1 cells is regulated by Hopx. Eur. J. Immunol. 2010, 40, 2993-3006.
12. Cheung, W. K.; Zhao, M.; Liu, Z.; Stevens, L. E.; Cao, P. D.; Fang, J. E.; Westbrook, T. F.; Nguyen, D. X. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 2013, 23, 725-738.
13. Takeda, N.; Jain, R.; LeBoeuf, M. R.; Wang, Q.; Lu, M. M.; Epstein, J. A. Interconversion between intestinal stem cell populations in distinct niches. Science 2011, 334, 1420-1424.
14. Takeda, N.; Jain, R.; Leboeuf, M. R.; Padmanabhan, A.; Wang, Q.; Li, L.; Lu, M. M.; Millar, S. E.; Epstein, J. A. Hopx expression defines a subset of multipotent hair follicle stem cells and a progenitor population primed to give rise to K6+ niche cells. Development 2013, 140, 1655-1664.
15. Sakakura, C.; Hagiwara, A.; Taniguchi, H.; Yamaguchi, T.; Yamagishi, H.; Takahashi, T.; Koyama, K.; Nakamura, Y.; Abe, T.; Inazawa, J. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br. J. Cancer 1999, 80, 2034-2039.
16. Wong, N.; Lai, P.; Lee, S. W.; Fan, S.; Pang, E.; Liew, C. T.; Sheng, Z.; Lau, J. W.; Johnson, P. J. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis. Am. J. Pathol. 1999, 154, 37-43.
17. Burger, A. M.; Zhang, X.; Li, H.; Ostrowski, J. L.; Beatty, B.; Venanzoni, M.; Papas, T.; Seth, A. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998, 16, 2459-2467.
18. Leon, M.; Kew, M. C. Loss of heterozygosity in chromosome 4q12-q13 in hepatocellular carcinoma in southern African blacks. Anticancer Res. 1996, 16, 349-351.
19. Chen, Y.; Pacyna-Gengelbach, M.; Deutschmann, N.; Niesporek, S.; Petersen, I. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. Int. J. Cancer 2007, 121, 1021-1027.
20. Ooki, A.; Yamashita, K.; Kikuchi, S.; Sakuramoto, S.; Katada, N.; Kokubo, K.; Kobayashi, H.; Kim, M. S.; Sidransky, D.; Watanabe, M. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene 2010, 29, 3263-3275.
21. Waraya, M.; Yamashita, K.; Katoh, H.; Ooki, A.; Kawamata, H.; Nishimiya, H.; Nakamura, K.; Ema, A.; Watanabe, M. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis. BMC Cancer 2012, 12, doi: 10. 1186/1471-2407-12-397.
22. Yamashita, K.; Upadhyay, S.; Osada, M.; Hoque, M. O.; Xiao, Y.; Mori, M.; Sato, F.; Meltzer, S. J.; Sidransky, D. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002, 2, 485-495.
23. Yamashita, K.; Kim, M. S.; Park, H. L.; Tokumaru, Y.; Osada, M.; Inoue, H.; Mori, M.; Sidransky, D. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol. Cancer Res. 2008, 6, 31-41.
24. Yamashita, K.; Sakuramoto, S.; Watanabe, M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg. Today 2011, 41, 24-38.
25. Lemaire, F.; Millon, R.; Muller, D.; Rabouel, Y.; Bracco, L.; Abecassis, J.; Wasylyk, B. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. Br. J. Cancer 2004, 91, 258-261.
26. Katoh, H.; Yamashita, K.; Waraya, M.; Margalit, O.; Ooki, A.; Tamaki, H.; Sakagami, H.; Kokubo, K.; Sidransky, D.; Watanabe, M. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer. Neoplasia 2012, 14, 559-571.
27. Chen, Y.; Petersen, S.; Pacyna-Gengelbach, M.; Pietas, A.; Petersen, I. Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 2003, 64, 450-458.
28. Asanoma, K.; Matsuda, T.; Kondo, H.; Kato, K.; Kishino, T.; Niikawa, N.; Wake, N.; Kato, H. NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics 2003, 81, 15-25.
29. Yamaguchi, S.; Asanoma, K.; Takao, T.; Kato, K.; Wake, N. Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int. J. Cancer 2009, 124, 2577-2588.
30. Harada, Y.; Kijima, K.; Shinmura, K.; Sakata, M.; Sakuraba, K.; Yokomizo, K.; Kitamura, Y.; Shirahata, A.; Goto, T.; Mizukami, H.; et al. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer. Anticancer Res. 2011, 31, 2889-2892.
31. Kim, M. S.; Yamashita, K.; Baek, J. H.; Park, H. L.; Carvalho, A. L.; Osada, M.; Hoque, M. O.; Upadhyay, S.; Mori, M.; Moon, C.; et al. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006, 66, 3409-3418.
32. Kim, M. S.; Lee, J.; Sidransky, D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010, 29, 181-206.
33. Kovarova, D.; Plachy, J.; Kosla, J.; Trejbalova, K.; Cermak, V.; Hejnar, J. Downregulation of the HOPX gene decreases metastatic activity in a chicken sarcoma cell line model and identifies genes associated with metastasis. Mol. Cancer Res. 2013, 11, 1235-1247.
34. Crowe, D. L.; Brown, T. N. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1999, 1, 368-372.
35. Kajanne, R.; Miettinen, P.; Mehlem, A.; Leivonen, S. K.; Birrer, M.; Foschi, M.; Kähäri, V. M.; Leppä, S. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell Physiol. 2007, 212, 489-497.
36. Dong, W.; Li, Y.; Gao, M.; Hu, M.; Li, X.; Mai, S.; Guo, N.; Yuan, S.; Song, L. IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation. Nucleic Acids Res. 2012, 40, 2940-2955.
37. Bae, S. K.; Bae, M. H.; Ahn, M. Y.; Son, M. J.; Lee, Y. M.; Bae, M. K.; Lee, O. H.; Park, B. C.; Kim, K. W. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 1999, 59, 5989-5994.
38. Worden, B.; Yang, X. P.; Lee, T. L.; Bagain, L.; Yeh, N. T.; Cohen, J. G.; Van Waes, C.; Chen, Z. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res. 2005, 65, 7071-7080.
39. Baron, V.; De Gregorio, G.; Krones-Herzig, A.; Virolle, T.; Calogero, A.; Urcis, R.; Mercola, D. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene 2003, 22, 4194-4204.
40. Herath, N. I.; Boyd, A. W. The role of Eph receptors and ephrin ligands in colorectal cancer. Int. J. Cancer 2010, 126, 2003-2011.
41. Biao-Xue, R.; Xi-Guang, C.; Shuan-ying, Y.; Wei, L.; Zong-juan, M. EphA2-dependent molecular targeting therapy for malignant tumors. Curr. Cancer Drug Targets 2011, 11, 1082-1097.
42. Binda, E.; Visioli, A.; Giani, F.; Lamorte, G.; Copetti, M.; Pitter, K. L.; Huse, J. T.; Cajola, L.; Zanetti, N.; di Meco, F.; et al. The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 2012, 22, 765-780.
43. Salaita, K.; Nair, P. M.; Petit, R. S.; Neve, R. M.; Das, D.; Gray, J. W.; Groves, J. T. Restriction of receptor movement alters cellular response: Physical force sensing by EphA2. Science 2010, 327, 1380-1385.
44. Lee, J. W.; Han, H. D.; Shahzad, M. M.; Kim, S. W.; Mangala, L. S.; Nick, A. M.; Lu, C.; Langley, R. R.; Schmandt, R.; Kim, H. S.; et al. EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J. Natl. Cancer Inst. 2009, 101, 1193-1205.
45. Miao, H.; Li, D. Q.; Mukherjee, A.; Guo, H.; Petty, A.; Cutter, J.; Basilion, J. P.; Sedor, J.; Wu, J.; Danielpour, D.; et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009, 16, 9-20.
46. Jain, A.; Tindell, C. A.; Laux, I.; Hunter, J. B.; Curran, J.; Galkin, A.; Afar, D. E.; Aronson, N.; Shak, S.; Natale, R. B.; et al. Epithelial membrane protein-1 is a biomarker of gefitinib resistance. Proc. Natl. Acad. Sci. USA 2005, 102, 11858-11863.
47. Karapetis, C. S.; Khambata-Ford, S.; Jonker, D. J.; O'Callaghan, C. J.; Tu, D.; Tebbutt, N. C.; Simes, R. J.; Chalchal, H.; Shapiro, J. D.; Robitaille, S.; et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 2008, 359, 1757-1765.
48. Carrato, A.; Gómez, A.; Escudero, P.; Chaves, M.; Rivera, F.; Marcuello, E.; González, E.; Grávalos, C.; Constenla, M.; Manzano, J. L.; et al. Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer. Clin. Transl. Oncol. 2013, 15, 705-711.
49. Harris, L. G.; Pannell, L. K.; Singh, S.; Samant, R. S.; Shevde, L. A. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61. Oncogene 2012, 31, 3370-3380.
50. Haque, I.; De, A.; Majumder, M.; Mehta, S.; McGregor, D.; Banerjee, S. K.; van Veldhuizen, P.; Banerjee, S. The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis. J. Biol. Chem. 2012, 287, 38569-38579.
51. Barker, N.; van Es, J. H.; Kuipers, J.; Kujala, P.; van den Born, M.; Cozijnsen, M.; Haegebarth, A.; Korving, J.; Begthel, H.; Peters, P. J.; et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449, 1003-1007.
52. Takahashi, H.; Ishii, H.; Nishida, N.; Takemasa, I.; Mizushima, T.; Ikeda, M.; Yokobori, T.; Mimori, K.; Yamamoto, H.; Sekimoto, M.; et al. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann. Surg. Oncol. 2011, 18, 1166-1174.